0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Biomarker POCT Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-17R13990
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Biomarker POCT Market Research Report 2023
BUY CHAPTERS

Global Biomarker POCT Market Research Report 2025

Code: QYRE-Auto-17R13990
Report
May 2025
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Biomarker POCT Market

The global market for Biomarker POCT was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Biomarker POCT is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Biomarker POCT is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Biomarker POCT include Roche, Abbott, Siemens Healthineers, Danaher, Assure Tech, BioMerieux, Bio-Rad Laboratories, Wondfo, Wuhan Easy Diagnosis, Getein Biotech, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Biomarker POCT, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biomarker POCT.
The Biomarker POCT market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biomarker POCT market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biomarker POCT manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Biomarker POCT Market Report

Report Metric Details
Report Name Biomarker POCT Market
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Roche, Abbott, Siemens Healthineers, Danaher, Assure Tech, BioMerieux, Bio-Rad Laboratories, Wondfo, Wuhan Easy Diagnosis, Getein Biotech, Beijing Hotgen Biotech Co.,ltd., Beijing Wantai BioPharm, Zhejiang Orient Gene Biotech Co.,Ltd., Sansure Biotech Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Biomarker POCT manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Biomarker POCT in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Biomarker POCT Market report?

Ans: The main players in the Biomarker POCT Market are Roche, Abbott, Siemens Healthineers, Danaher, Assure Tech, BioMerieux, Bio-Rad Laboratories, Wondfo, Wuhan Easy Diagnosis, Getein Biotech, Beijing Hotgen Biotech Co.,ltd., Beijing Wantai BioPharm, Zhejiang Orient Gene Biotech Co.,Ltd., Sansure Biotech Inc.

What are the Application segmentation covered in the Biomarker POCT Market report?

Ans: The Applications covered in the Biomarker POCT Market report are Pathogen Nucleic Acid, Antibody, Pathogen Protein, Circulating MicroRNA

What are the Type segmentation covered in the Biomarker POCT Market report?

Ans: The Types covered in the Biomarker POCT Market report are Lateral Immunoassay, Microfluidics, Plasma Technique, Other

Recommended Reports

Biomarker Diagnostics

POCT Devices

Cancer and Disease Tests

1 Biomarker POCT Market Overview
1.1 Product Definition
1.2 Biomarker POCT by Type
1.2.1 Global Biomarker POCT Market Value Comparison by Type (2024 VS 2031)
1.2.2 Lateral Immunoassay
1.2.3 Microfluidics
1.2.4 Plasma Technique
1.2.5 Other
1.3 Biomarker POCT by Application
1.3.1 Global Biomarker POCT Market Value by Application (2024 VS 2031)
1.3.2 Pathogen Nucleic Acid
1.3.3 Antibody
1.3.4 Pathogen Protein
1.3.5 Circulating MicroRNA
1.4 Global Biomarker POCT Market Size Estimates and Forecasts
1.4.1 Global Biomarker POCT Revenue 2020-2031
1.4.2 Global Biomarker POCT Sales 2020-2031
1.4.3 Global Biomarker POCT Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Biomarker POCT Market Competition by Manufacturers
2.1 Global Biomarker POCT Sales Market Share by Manufacturers (2020-2025)
2.2 Global Biomarker POCT Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Biomarker POCT Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Biomarker POCT, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Biomarker POCT, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Biomarker POCT, Product Type & Application
2.7 Global Key Manufacturers of Biomarker POCT, Date of Enter into This Industry
2.8 Global Biomarker POCT Market Competitive Situation and Trends
2.8.1 Global Biomarker POCT Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Biomarker POCT Players Market Share by Revenue
2.8.3 Global Biomarker POCT Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Biomarker POCT Market Scenario by Region
3.1 Global Biomarker POCT Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Biomarker POCT Sales by Region: 2020-2031
3.2.1 Global Biomarker POCT Sales by Region: 2020-2025
3.2.2 Global Biomarker POCT Sales by Region: 2026-2031
3.3 Global Biomarker POCT Revenue by Region: 2020-2031
3.3.1 Global Biomarker POCT Revenue by Region: 2020-2025
3.3.2 Global Biomarker POCT Revenue by Region: 2026-2031
3.4 North America Biomarker POCT Market Facts & Figures by Country
3.4.1 North America Biomarker POCT Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Biomarker POCT Sales by Country (2020-2031)
3.4.3 North America Biomarker POCT Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Biomarker POCT Market Facts & Figures by Country
3.5.1 Europe Biomarker POCT Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Biomarker POCT Sales by Country (2020-2031)
3.5.3 Europe Biomarker POCT Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Biomarker POCT Market Facts & Figures by Region
3.6.1 Asia Pacific Biomarker POCT Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Biomarker POCT Sales by Region (2020-2031)
3.6.3 Asia Pacific Biomarker POCT Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Biomarker POCT Market Facts & Figures by Country
3.7.1 Latin America Biomarker POCT Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Biomarker POCT Sales by Country (2020-2031)
3.7.3 Latin America Biomarker POCT Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Biomarker POCT Market Facts & Figures by Country
3.8.1 Middle East and Africa Biomarker POCT Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Biomarker POCT Sales by Country (2020-2031)
3.8.3 Middle East and Africa Biomarker POCT Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Biomarker POCT Sales by Type (2020-2031)
4.1.1 Global Biomarker POCT Sales by Type (2020-2025)
4.1.2 Global Biomarker POCT Sales by Type (2026-2031)
4.1.3 Global Biomarker POCT Sales Market Share by Type (2020-2031)
4.2 Global Biomarker POCT Revenue by Type (2020-2031)
4.2.1 Global Biomarker POCT Revenue by Type (2020-2025)
4.2.2 Global Biomarker POCT Revenue by Type (2026-2031)
4.2.3 Global Biomarker POCT Revenue Market Share by Type (2020-2031)
4.3 Global Biomarker POCT Price by Type (2020-2031)
5 Segment by Application
5.1 Global Biomarker POCT Sales by Application (2020-2031)
5.1.1 Global Biomarker POCT Sales by Application (2020-2025)
5.1.2 Global Biomarker POCT Sales by Application (2026-2031)
5.1.3 Global Biomarker POCT Sales Market Share by Application (2020-2031)
5.2 Global Biomarker POCT Revenue by Application (2020-2031)
5.2.1 Global Biomarker POCT Revenue by Application (2020-2025)
5.2.2 Global Biomarker POCT Revenue by Application (2026-2031)
5.2.3 Global Biomarker POCT Revenue Market Share by Application (2020-2031)
5.3 Global Biomarker POCT Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Biomarker POCT Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Roche Biomarker POCT Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Abbott
6.2.1 Abbott Company Information
6.2.2 Abbott Description and Business Overview
6.2.3 Abbott Biomarker POCT Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Abbott Biomarker POCT Product Portfolio
6.2.5 Abbott Recent Developments/Updates
6.3 Siemens Healthineers
6.3.1 Siemens Healthineers Company Information
6.3.2 Siemens Healthineers Description and Business Overview
6.3.3 Siemens Healthineers Biomarker POCT Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Siemens Healthineers Biomarker POCT Product Portfolio
6.3.5 Siemens Healthineers Recent Developments/Updates
6.4 Danaher
6.4.1 Danaher Company Information
6.4.2 Danaher Description and Business Overview
6.4.3 Danaher Biomarker POCT Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Danaher Biomarker POCT Product Portfolio
6.4.5 Danaher Recent Developments/Updates
6.5 Assure Tech
6.5.1 Assure Tech Company Information
6.5.2 Assure Tech Description and Business Overview
6.5.3 Assure Tech Biomarker POCT Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Assure Tech Biomarker POCT Product Portfolio
6.5.5 Assure Tech Recent Developments/Updates
6.6 BioMerieux
6.6.1 BioMerieux Company Information
6.6.2 BioMerieux Description and Business Overview
6.6.3 BioMerieux Biomarker POCT Sales, Revenue and Gross Margin (2020-2025)
6.6.4 BioMerieux Biomarker POCT Product Portfolio
6.6.5 BioMerieux Recent Developments/Updates
6.7 Bio-Rad Laboratories
6.7.1 Bio-Rad Laboratories Company Information
6.7.2 Bio-Rad Laboratories Description and Business Overview
6.7.3 Bio-Rad Laboratories Biomarker POCT Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Bio-Rad Laboratories Biomarker POCT Product Portfolio
6.7.5 Bio-Rad Laboratories Recent Developments/Updates
6.8 Wondfo
6.8.1 Wondfo Company Information
6.8.2 Wondfo Description and Business Overview
6.8.3 Wondfo Biomarker POCT Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Wondfo Biomarker POCT Product Portfolio
6.8.5 Wondfo Recent Developments/Updates
6.9 Wuhan Easy Diagnosis
6.9.1 Wuhan Easy Diagnosis Company Information
6.9.2 Wuhan Easy Diagnosis Description and Business Overview
6.9.3 Wuhan Easy Diagnosis Biomarker POCT Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Wuhan Easy Diagnosis Biomarker POCT Product Portfolio
6.9.5 Wuhan Easy Diagnosis Recent Developments/Updates
6.10 Getein Biotech
6.10.1 Getein Biotech Company Information
6.10.2 Getein Biotech Description and Business Overview
6.10.3 Getein Biotech Biomarker POCT Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Getein Biotech Biomarker POCT Product Portfolio
6.10.5 Getein Biotech Recent Developments/Updates
6.11 Beijing Hotgen Biotech Co.,ltd.
6.11.1 Beijing Hotgen Biotech Co.,ltd. Company Information
6.11.2 Beijing Hotgen Biotech Co.,ltd. Description and Business Overview
6.11.3 Beijing Hotgen Biotech Co.,ltd. Biomarker POCT Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Beijing Hotgen Biotech Co.,ltd. Biomarker POCT Product Portfolio
6.11.5 Beijing Hotgen Biotech Co.,ltd. Recent Developments/Updates
6.12 Beijing Wantai BioPharm
6.12.1 Beijing Wantai BioPharm Company Information
6.12.2 Beijing Wantai BioPharm Description and Business Overview
6.12.3 Beijing Wantai BioPharm Biomarker POCT Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Beijing Wantai BioPharm Biomarker POCT Product Portfolio
6.12.5 Beijing Wantai BioPharm Recent Developments/Updates
6.13 Zhejiang Orient Gene Biotech Co.,Ltd.
6.13.1 Zhejiang Orient Gene Biotech Co.,Ltd. Company Information
6.13.2 Zhejiang Orient Gene Biotech Co.,Ltd. Description and Business Overview
6.13.3 Zhejiang Orient Gene Biotech Co.,Ltd. Biomarker POCT Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Zhejiang Orient Gene Biotech Co.,Ltd. Biomarker POCT Product Portfolio
6.13.5 Zhejiang Orient Gene Biotech Co.,Ltd. Recent Developments/Updates
6.14 Sansure Biotech Inc.
6.14.1 Sansure Biotech Inc. Company Information
6.14.2 Sansure Biotech Inc. Description and Business Overview
6.14.3 Sansure Biotech Inc. Biomarker POCT Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Sansure Biotech Inc. Biomarker POCT Product Portfolio
6.14.5 Sansure Biotech Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Biomarker POCT Industry Chain Analysis
7.2 Biomarker POCT Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Biomarker POCT Production Mode & Process Analysis
7.4 Biomarker POCT Sales and Marketing
7.4.1 Biomarker POCT Sales Channels
7.4.2 Biomarker POCT Distributors
7.5 Biomarker POCT Customer Analysis
8 Biomarker POCT Market Dynamics
8.1 Biomarker POCT Industry Trends
8.2 Biomarker POCT Market Drivers
8.3 Biomarker POCT Market Challenges
8.4 Biomarker POCT Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Biomarker POCT Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Biomarker POCT Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Biomarker POCT Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Biomarker POCT Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Biomarker POCT Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Biomarker POCT Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Biomarker POCT Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Biomarker POCT Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Biomarker POCT, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Biomarker POCT, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Biomarker POCT, Product Type & Application
 Table 12. Global Key Manufacturers of Biomarker POCT, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Biomarker POCT by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biomarker POCT as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Biomarker POCT Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Biomarker POCT Sales by Region (2020-2025) & (K Units)
 Table 18. Global Biomarker POCT Sales Market Share by Region (2020-2025)
 Table 19. Global Biomarker POCT Sales by Region (2026-2031) & (K Units)
 Table 20. Global Biomarker POCT Sales Market Share by Region (2026-2031)
 Table 21. Global Biomarker POCT Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Biomarker POCT Revenue Market Share by Region (2020-2025)
 Table 23. Global Biomarker POCT Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Biomarker POCT Revenue Market Share by Region (2026-2031)
 Table 25. North America Biomarker POCT Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Biomarker POCT Sales by Country (2020-2025) & (K Units)
 Table 27. North America Biomarker POCT Sales by Country (2026-2031) & (K Units)
 Table 28. North America Biomarker POCT Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Biomarker POCT Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Biomarker POCT Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Biomarker POCT Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Biomarker POCT Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Biomarker POCT Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Biomarker POCT Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Biomarker POCT Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Biomarker POCT Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Biomarker POCT Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Biomarker POCT Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Biomarker POCT Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Biomarker POCT Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Biomarker POCT Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Biomarker POCT Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Biomarker POCT Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Biomarker POCT Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Biomarker POCT Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Biomarker POCT Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Biomarker POCT Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Biomarker POCT Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Biomarker POCT Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Biomarker POCT Sales (K Units) by Type (2020-2025)
 Table 51. Global Biomarker POCT Sales (K Units) by Type (2026-2031)
 Table 52. Global Biomarker POCT Sales Market Share by Type (2020-2025)
 Table 53. Global Biomarker POCT Sales Market Share by Type (2026-2031)
 Table 54. Global Biomarker POCT Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Biomarker POCT Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Biomarker POCT Revenue Market Share by Type (2020-2025)
 Table 57. Global Biomarker POCT Revenue Market Share by Type (2026-2031)
 Table 58. Global Biomarker POCT Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Biomarker POCT Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Biomarker POCT Sales (K Units) by Application (2020-2025)
 Table 61. Global Biomarker POCT Sales (K Units) by Application (2026-2031)
 Table 62. Global Biomarker POCT Sales Market Share by Application (2020-2025)
 Table 63. Global Biomarker POCT Sales Market Share by Application (2026-2031)
 Table 64. Global Biomarker POCT Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Biomarker POCT Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Biomarker POCT Revenue Market Share by Application (2020-2025)
 Table 67. Global Biomarker POCT Revenue Market Share by Application (2026-2031)
 Table 68. Global Biomarker POCT Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Biomarker POCT Price (US$/Unit) by Application (2026-2031)
 Table 70. Roche Company Information
 Table 71. Roche Description and Business Overview
 Table 72. Roche Biomarker POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Roche Biomarker POCT Product
 Table 74. Roche Recent Developments/Updates
 Table 75. Abbott Company Information
 Table 76. Abbott Description and Business Overview
 Table 77. Abbott Biomarker POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Abbott Biomarker POCT Product
 Table 79. Abbott Recent Developments/Updates
 Table 80. Siemens Healthineers Company Information
 Table 81. Siemens Healthineers Description and Business Overview
 Table 82. Siemens Healthineers Biomarker POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Siemens Healthineers Biomarker POCT Product
 Table 84. Siemens Healthineers Recent Developments/Updates
 Table 85. Danaher Company Information
 Table 86. Danaher Description and Business Overview
 Table 87. Danaher Biomarker POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Danaher Biomarker POCT Product
 Table 89. Danaher Recent Developments/Updates
 Table 90. Assure Tech Company Information
 Table 91. Assure Tech Description and Business Overview
 Table 92. Assure Tech Biomarker POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Assure Tech Biomarker POCT Product
 Table 94. Assure Tech Recent Developments/Updates
 Table 95. BioMerieux Company Information
 Table 96. BioMerieux Description and Business Overview
 Table 97. BioMerieux Biomarker POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. BioMerieux Biomarker POCT Product
 Table 99. BioMerieux Recent Developments/Updates
 Table 100. Bio-Rad Laboratories Company Information
 Table 101. Bio-Rad Laboratories Description and Business Overview
 Table 102. Bio-Rad Laboratories Biomarker POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Bio-Rad Laboratories Biomarker POCT Product
 Table 104. Bio-Rad Laboratories Recent Developments/Updates
 Table 105. Wondfo Company Information
 Table 106. Wondfo Description and Business Overview
 Table 107. Wondfo Biomarker POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Wondfo Biomarker POCT Product
 Table 109. Wondfo Recent Developments/Updates
 Table 110. Wuhan Easy Diagnosis Company Information
 Table 111. Wuhan Easy Diagnosis Description and Business Overview
 Table 112. Wuhan Easy Diagnosis Biomarker POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Wuhan Easy Diagnosis Biomarker POCT Product
 Table 114. Wuhan Easy Diagnosis Recent Developments/Updates
 Table 115. Getein Biotech Company Information
 Table 116. Getein Biotech Description and Business Overview
 Table 117. Getein Biotech Biomarker POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Getein Biotech Biomarker POCT Product
 Table 119. Getein Biotech Recent Developments/Updates
 Table 120. Beijing Hotgen Biotech Co.,ltd. Company Information
 Table 121. Beijing Hotgen Biotech Co.,ltd. Description and Business Overview
 Table 122. Beijing Hotgen Biotech Co.,ltd. Biomarker POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Beijing Hotgen Biotech Co.,ltd. Biomarker POCT Product
 Table 124. Beijing Hotgen Biotech Co.,ltd. Recent Developments/Updates
 Table 125. Beijing Wantai BioPharm Company Information
 Table 126. Beijing Wantai BioPharm Description and Business Overview
 Table 127. Beijing Wantai BioPharm Biomarker POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Beijing Wantai BioPharm Biomarker POCT Product
 Table 129. Beijing Wantai BioPharm Recent Developments/Updates
 Table 130. Zhejiang Orient Gene Biotech Co.,Ltd. Company Information
 Table 131. Zhejiang Orient Gene Biotech Co.,Ltd. Description and Business Overview
 Table 132. Zhejiang Orient Gene Biotech Co.,Ltd. Biomarker POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Zhejiang Orient Gene Biotech Co.,Ltd. Biomarker POCT Product
 Table 134. Zhejiang Orient Gene Biotech Co.,Ltd. Recent Developments/Updates
 Table 135. Sansure Biotech Inc. Company Information
 Table 136. Sansure Biotech Inc. Description and Business Overview
 Table 137. Sansure Biotech Inc. Biomarker POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Sansure Biotech Inc. Biomarker POCT Product
 Table 139. Sansure Biotech Inc. Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Biomarker POCT Distributors List
 Table 143. Biomarker POCT Customers List
 Table 144. Biomarker POCT Market Trends
 Table 145. Biomarker POCT Market Drivers
 Table 146. Biomarker POCT Market Challenges
 Table 147. Biomarker POCT Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Biomarker POCT
 Figure 2. Global Biomarker POCT Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Biomarker POCT Market Share by Type: 2024 & 2031
 Figure 4. Lateral Immunoassay Product Picture
 Figure 5. Microfluidics Product Picture
 Figure 6. Plasma Technique Product Picture
 Figure 7. Other Product Picture
 Figure 8. Global Biomarker POCT Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Biomarker POCT Market Share by Application: 2024 & 2031
 Figure 10. Pathogen Nucleic Acid
 Figure 11. Antibody
 Figure 12. Pathogen Protein
 Figure 13. Circulating MicroRNA
 Figure 14. Global Biomarker POCT Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Biomarker POCT Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Biomarker POCT Sales (2020-2031) & (K Units)
 Figure 17. Global Biomarker POCT Average Price (US$/Unit) & (2020-2031)
 Figure 18. Biomarker POCT Report Years Considered
 Figure 19. Biomarker POCT Sales Share by Manufacturers in 2024
 Figure 20. Global Biomarker POCT Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Biomarker POCT Players: Market Share by Revenue in Biomarker POCT in 2024
 Figure 22. Biomarker POCT Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Biomarker POCT Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Biomarker POCT Sales Market Share by Country (2020-2031)
 Figure 25. North America Biomarker POCT Revenue Market Share by Country (2020-2031)
 Figure 26. United States Biomarker POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Biomarker POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Biomarker POCT Sales Market Share by Country (2020-2031)
 Figure 29. Europe Biomarker POCT Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Biomarker POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Biomarker POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Biomarker POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Biomarker POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Biomarker POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Biomarker POCT Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Biomarker POCT Revenue Market Share by Region (2020-2031)
 Figure 37. China Biomarker POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Biomarker POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Biomarker POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Biomarker POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Biomarker POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. China Taiwan Biomarker POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Southeast Asia Biomarker POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Biomarker POCT Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Biomarker POCT Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Biomarker POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Biomarker POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Biomarker POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Biomarker POCT Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Biomarker POCT Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Biomarker POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Biomarker POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Biomarker POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Biomarker POCT by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Biomarker POCT by Type (2020-2031)
 Figure 56. Global Biomarker POCT Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Biomarker POCT by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Biomarker POCT by Application (2020-2031)
 Figure 59. Global Biomarker POCT Price (US$/Unit) by Application (2020-2031)
 Figure 60. Biomarker POCT Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart